Publish on an established, multi-topic publication read by a professional audience, with real editorial review, a named byline and do-follow links.
Some figures are awaiting verification and are marked as such. We publish a number only once we can evidence it.
Final pricing is confirmed on enquiry.
Technology, AI, Business, Finance, Health & Beauty and Lifestyle.
Minimum 800 words. Long enough to be useful, tight enough to be read.
1 do-follow backlink on a Standard placement and 2 on a Featured one, plus one further link to a credible source or a second website.
Original, accurate, non-promotional writing, with sources where claims need them.
Gambling, drugs and illegal activity, adult content, payday lending, unlicensed financial promotions and health misinformation. No exceptions, at any price.
Every paid placement is labelled Sponsored above the headline. That is a legal requirement, not a setting.
The full standards, including everything we refuse outright, are in the editorial guidelines. Read them before you pay for anything.
From confirmed placement to live post in 24 hours to 48 hours.
Tell us what you want to place. We confirm fit and price.
We issue a confirmation. Payment secures the slot.
You upload the article through the private link we send you.
An editor reviews it and it goes live in the right section.
Google has publicly discouraged guest posting done purely for links since at least 2014, and its current spam policies explicitly name optimized anchor text in guest posts as a link spam signal.
Treating detailed passenger flow modeling as a standard step early in design, rather than a specialist add-on brought in only when a problem is suspected, is the difference between catching a capacity shortfall on paper and discovering it in a lobby full of frustrated tenants waiting for a lift that was never going to be enough.
Feeling like nothing has worked is a common experience among people with treatment-resistant depression, but it is not the same thing as having exhausted the actual options. The category exists precisely because the standard sequence of oral antidepressants does not work for everyone, and the treatments developed specifically for this population, including esketamine, exist because researchers recognized that gap and built something to address it directly.
We publish one contribution a month at no cost, for writers with something genuinely worth reading. It goes through exactly the same editorial review as a paid placement and has to meet the same standards. Send us the piece, or the idea, and if it is a fit we will tell you.
First come, first served each month. A free contribution is editorial, not advertising, so it carries no sponsored label — which also means it cannot be written around a commercial link.
Pitch a free contributionThe questions contributors ask most.
Tell us what you want to place. We reply with availability and a confirmation, and send you a private link to upload the article once the placement is booked.
Every placement is labelled as sponsored, in line with UK advertising rules. Prefer email? Write to [email protected]. Browse Technology or Business to see the standard we publish to.